Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population

NCT00641784 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Labor, Premature

Interventions

DRUG: Magnesium
DRUG: Nifedlipine

Sponsor

MemorialCare